S&P 500   3,110.29 (+0.22%)
DOW   27,875.62 (+0.39%)
QQQ   201.83 (+0.06%)
CGC   18.41 (-9.27%)
BABA   186.78 (+1.04%)
GE   11.55 (+0.17%)
T   37.75 (+0.40%)
ACB   2.70 (-13.46%)
F   8.89 (+2.07%)
PRI   130.63 (+0.14%)
NFLX   310.48 (-0.39%)
BAC   33.18 (+1.04%)
DIS   148.29 (+0.95%)
S&P 500   3,110.29 (+0.22%)
DOW   27,875.62 (+0.39%)
QQQ   201.83 (+0.06%)
CGC   18.41 (-9.27%)
BABA   186.78 (+1.04%)
GE   11.55 (+0.17%)
T   37.75 (+0.40%)
ACB   2.70 (-13.46%)
F   8.89 (+2.07%)
PRI   130.63 (+0.14%)
NFLX   310.48 (-0.39%)
BAC   33.18 (+1.04%)
DIS   148.29 (+0.95%)
S&P 500   3,110.29 (+0.22%)
DOW   27,875.62 (+0.39%)
QQQ   201.83 (+0.06%)
CGC   18.41 (-9.27%)
BABA   186.78 (+1.04%)
GE   11.55 (+0.17%)
T   37.75 (+0.40%)
ACB   2.70 (-13.46%)
F   8.89 (+2.07%)
PRI   130.63 (+0.14%)
NFLX   310.48 (-0.39%)
BAC   33.18 (+1.04%)
DIS   148.29 (+0.95%)
S&P 500   3,110.29 (+0.22%)
DOW   27,875.62 (+0.39%)
QQQ   201.83 (+0.06%)
CGC   18.41 (-9.27%)
BABA   186.78 (+1.04%)
GE   11.55 (+0.17%)
T   37.75 (+0.40%)
ACB   2.70 (-13.46%)
F   8.89 (+2.07%)
PRI   130.63 (+0.14%)
NFLX   310.48 (-0.39%)
BAC   33.18 (+1.04%)
DIS   148.29 (+0.95%)
Log in

Misonix Stock Price, Forecast & Analysis (NASDAQ:MSON)

$21.41
+0.61 (+2.93 %)
(As of 11/22/2019 04:00 PM ET)
Today's Range
$20.75
Now: $21.41
$22.20
50-Day Range
$16.52
MA: $17.95
$20.89
52-Week Range
$14.13
Now: $21.41
$27.54
Volume267,800 shs
Average Volume46,934 shs
Market Capitalization$328.75 million
P/E RatioN/A
Dividend YieldN/A
Beta0.3
Misonix, Inc, together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Read More…

Industry, Sector and Symbol

Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:MSON
CUSIPN/A
Phone631-694-9555

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$38.85 million
Book Value$8.55 per share

Profitability

Net Income$-7,390,000.00

Miscellaneous

Employees118
Market Cap$328.75 million
Next Earnings Date2/5/2020 (Estimated)
OptionableNot Optionable

Receive MSON News and Ratings via Email

Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter.


Misonix (NASDAQ:MSON) Frequently Asked Questions

What is Misonix's stock symbol?

Misonix trades on the NASDAQ under the ticker symbol "MSON."

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) released its earnings results on Thursday, November, 7th. The medical equipment provider reported $0.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.17) by $0.34. The medical equipment provider had revenue of $11.15 million for the quarter. Misonix had a negative net margin of 7.33% and a negative return on equity of 3.35%. View Misonix's Earnings History.

When is Misonix's next earnings date?

Misonix is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Misonix.

What price target have analysts set for MSON?

2 Wall Street analysts have issued 12-month price targets for Misonix's stock. Their forecasts range from $27.00 to $30.00. On average, they expect Misonix's stock price to reach $28.50 in the next year. This suggests a possible upside of 33.1% from the stock's current price. View Analyst Price Targets for Misonix.

What is the consensus analysts' recommendation for Misonix?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Misonix.

Has Misonix been receiving favorable news coverage?

News coverage about MSON stock has trended somewhat negative recently, InfoTrie reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Misonix earned a news sentiment score of -1.9 on InfoTrie's scale. They also gave headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Misonix.

Who are some of Misonix's key competitors?

What other stocks do shareholders of Misonix own?

Who are Misonix's key executives?

Misonix's management team includes the folowing people:
  • Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 49)
  • Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 63)
  • Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 52)
  • Ms. Sharon W. Klugewicz, Chief Operating Officer (Age 51)
  • Mr. John J. Salerno, VP of Quality and Regulatory Affairs & Chief Compliance Officer (Age 64)

Who are Misonix's major shareholders?

Misonix's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Essex Investment Management Co. LLC (0.96%), Ingalls & Snyder LLC (0.56%) and Meeder Asset Management Inc. (0.02%). Company insiders that own Misonix stock include Christopher H Wright, Joseph J Brennan, Joseph P Dwyer, Patrick A Mcbrayer, Sharon W Klugewicz and Thomas M Patton. View Institutional Ownership Trends for Misonix.

Which institutional investors are selling Misonix stock?

MSON stock was sold by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC and Ingalls & Snyder LLC. Company insiders that have sold Misonix company stock in the last year include Christopher H Wright and Joseph J Brennan. View Insider Buying and Selling for Misonix.

Which institutional investors are buying Misonix stock?

MSON stock was bought by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc.. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer, Patrick A Mcbrayer, Sharon W Klugewicz and Thomas M Patton. View Insider Buying and Selling for Misonix.

How do I buy shares of Misonix?

Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Misonix's stock price today?

One share of MSON stock can currently be purchased for approximately $21.41.

How big of a company is Misonix?

Misonix has a market capitalization of $328.75 million and generates $38.85 million in revenue each year. Misonix employs 118 workers across the globe.View Additional Information About Misonix.

What is Misonix's official website?

The official website for Misonix is http://www.misonix.com/.

How can I contact Misonix?

Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.


MarketBeat Community Rating for Misonix (NASDAQ MSON)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  95 (Vote Outperform)
Underperform Votes:  115 (Vote Underperform)
Total Votes:  210
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel